Shares of National Research Corporation (NRC) have fallen 10% since the company reported a net loss of $0.1 million for the second quarter of 2025, significantly down from a net income of $6.2 million in the same quarter last year. The company’s revenues decreased 2.8% to $34 million, while adjusted net income per share rose to 28 cents from 26 cents year-over-year. In comparison, the S&P 500 index saw a minor decline of 0.7% during the same period.
Key financial metrics revealed an adjusted EBITDA of $10.3 million, reflecting a margin of 30.3%. The decline in net results was primarily attributed to $6.6 million in non-recurring executive compensation expenses. Despite this, total recurring contract value (TRCV) grew 2% sequentially, marking three consecutive quarters of growth.
NRC’s balance sheet showed cash reserves at $5.3 million as of June 30, 2025, up from $4.2 million, while total debt increased to $81 million from $62.7 million. The board also declared a quarterly dividend of 12 cents per share, payable on October 10, 2025, to shareholders of record on September 26, 2025.
